Genfit.fr

Categories: New newsletter subcribe

119Newsletters

0Subscriptions

Click here to subscribe to Genfit.fr

Newsletters

GENFIT: Sweeping approval of OCEANEs buyb ack and amendments of terms

Genfit.fr

Last Monday at 18:43
GENFIT announces that its Extraordinary G eneral Meeting on second notice will be held January 25, 2021 and informs th e OCEANEs holders of certain procedures for the Bondholders’ Meeting of J anuary 25, 2021

Genfit.fr

14 days ago
January 13, 2021 Extraordinary Shareholders Meeting: Wide support for the resoluti ons submitted to the shareholders’ vote but quorum not met on first conv ening

Genfit.fr

15 days ago
GENFIT Informs its Shareholders of Certai n Procedures for the Extraordinary Genera l Meeting of January 13, 2021

Genfit.fr

19 days ago
GENFIT to Present at Upcoming Investor Conferences and Host a PBC KOL Event

Genfit.fr

21 days ago
GENFIT: Renegotiation of the OCEANEs Conv ertible Bond Terms: Availability of Prosp ectus Relating to the Admission of New Shares Following Conversion of the OCEANE s

Genfit.fr

1 month ago
GENFIT announces the successful completion of a key milestone in the partial buy back and amendment of its OCEANEs

Genfit.fr

1 month ago
GENFIT announces satisfactory preliminary r esults of its OCEANEs’ partial bu yback offer

Genfit.fr

1 month ago
GENFIT Announces Final Terms For Proposed Renegotiation of 2022 OCEANE Convertible Bonds

Genfit.fr

2 months ago
GENFIT: New Data Presented at AASLD The Liver Meeting Digital Experience™

Genfit.fr

2 months ago
GENFIT: Third Quarter 2020 Financial Info rmation and Launch of Renegotiation of Convertible Bond

Genfit.fr

2 months ago
GENFIT: First Half-Year 2020 Financial Re port and New Corporate Strategy

Genfit.fr

3 months ago
GENFIT and LabCorp Sign Exclusive Agreeme nt to Commercialize a Novel Diagnostic Test for Liver Disease

Genfit.fr

4 months ago
GENFIT Announces First Patient First Visi t for ELATIVE Phase 3 Study Evaluating Elafibranor in PBC

Genfit.fr

4 months ago
GENFIT To Announce First Half-Year 2020 Financial Results and New Corporate Strat egy on September 30, 2020

Genfit.fr

4 months ago
GENFIT Announces Two Oral Presentations a t the Digital International Liver Congres s™ 2020

Genfit.fr

5 months ago
GENFIT Announces Pivotal Publication of N IS4™ Technology to Identify Patient s with At-Risk NASH in The Lancet Gas troenterology & Hepatology

Genfit.fr

5 months ago
GENFIT: Provides Initial Update on Corpor ate Strategy

Genfit.fr

6 months ago
GENFIT: Enhances Board of Directors with Two Strategic Appointments

Genfit.fr

6 months ago
GENFIT: June 30, 2020 Annual Shareholders Meeting results

Genfit.fr

7 months ago

© 2021